CN1814245A - 一种治疗颈椎病的中成药 - Google Patents
一种治疗颈椎病的中成药 Download PDFInfo
- Publication number
- CN1814245A CN1814245A CN 200510045395 CN200510045395A CN1814245A CN 1814245 A CN1814245 A CN 1814245A CN 200510045395 CN200510045395 CN 200510045395 CN 200510045395 A CN200510045395 A CN 200510045395A CN 1814245 A CN1814245 A CN 1814245A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- root
- medicine
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 208000029761 vertebral disease Diseases 0.000 title abstract 3
- 241000903946 Clematidis Species 0.000 claims abstract description 8
- 239000009636 Huang Qi Substances 0.000 claims abstract description 8
- 206010041591 Spinal osteoarthritis Diseases 0.000 claims description 17
- 208000036319 cervical spondylosis Diseases 0.000 claims description 17
- 208000005801 spondylosis Diseases 0.000 claims description 17
- 241000628997 Flos Species 0.000 claims description 14
- 241000218176 Corydalis Species 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 25
- 229940079593 drug Drugs 0.000 abstract description 9
- 208000024891 symptom Diseases 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 6
- 239000002775 capsule Substances 0.000 abstract description 5
- 241000213006 Angelica dahurica Species 0.000 abstract 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 235000006463 Brassica alba Nutrition 0.000 abstract 1
- 244000140786 Brassica hirta Species 0.000 abstract 1
- 235000011371 Brassica hirta Nutrition 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 241001537328 Corydalis decumbens Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241000305492 Gastrodia Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000208682 Liquidambar Species 0.000 abstract 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 239000001215 curcuma longa l. root Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 238000009700 powder processing Methods 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 21
- 239000000796 flavoring agent Substances 0.000 description 21
- 235000019634 flavors Nutrition 0.000 description 21
- 230000001737 promoting effect Effects 0.000 description 20
- 230000017531 blood circulation Effects 0.000 description 16
- 210000004185 liver Anatomy 0.000 description 16
- 206010062717 Increased upper airway secretion Diseases 0.000 description 15
- 208000026435 phlegm Diseases 0.000 description 15
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 12
- 230000004087 circulation Effects 0.000 description 12
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 210000003414 extremity Anatomy 0.000 description 7
- 231100000862 numbness Toxicity 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000001354 painful effect Effects 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 1
- JLUQTCXCAFSSLD-NXEZZACHSA-N Anemonin Chemical compound C1=CC(=O)O[C@]11[C@@]2(C=CC(=O)O2)CC1 JLUQTCXCAFSSLD-NXEZZACHSA-N 0.000 description 1
- JLUQTCXCAFSSLD-UHFFFAOYSA-N Anemonin Natural products C1=CC(=O)OC11C2(C=CC(=O)O2)CC1 JLUQTCXCAFSSLD-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 1
- 241000208809 Carthamus Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 241001439614 Myron Species 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044074 Torticollis Diseases 0.000 description 1
- FZPYMZUVXJUAQA-ZDUSSCGKSA-N Turmerone Chemical compound CC(C)=CC(=O)C[C@H](C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-ZDUSSCGKSA-N 0.000 description 1
- FZPYMZUVXJUAQA-UHFFFAOYSA-N Turmerone Natural products CC(C)=CC(=O)CC(C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-UHFFFAOYSA-N 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- XOCANRBEOZQNAQ-KBPBESRZSA-N alpha-turmerone Natural products O=C(/C=C(\C)/C)C[C@H](C)[C@H]1C=CC(C)=CC1 XOCANRBEOZQNAQ-KBPBESRZSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- TZFWDZFKRBELIQ-UHFFFAOYSA-N chlorzoxazone Chemical compound ClC1=CC=C2OC(O)=NC2=C1 TZFWDZFKRBELIQ-UHFFFAOYSA-N 0.000 description 1
- 229960003633 chlorzoxazone Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ICJBPZBRDLONIF-UHFFFAOYSA-N hexane-1,1,1,2,2,3-hexol Chemical compound CCCC(O)C(O)(O)C(O)(O)O ICJBPZBRDLONIF-UHFFFAOYSA-N 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- -1 saccharide Saponin Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗颈椎病的中成药,其特征在于它是由桂枝、夏天无、当归、川芎、红花、刘寄奴、姜黄、路路通、羌活、白芷、威灵仙、桑枝、天南星、白芥子、葛根、双花、黄芩、天蔴、黄芪、狗脊、续断等优质中药原料按一定重量比例,经采用配制、熬制、微粉加工等现代加工技术加工后,灌制成胶囊服用,能有效地治疗颈椎病。具有疗效显著,清除症状迅速,服用方便,无毒副作用,治疗成本低,治愈率高,服用方便等特点。经临床试验,有效率达96.8%,治愈率达75.8%。
Description
所属技术领域
本发明涉及一种中成药,具体的说是一种治疗颈椎病的中成药。
背景技术
颈椎病是一种严重危害人体身心健康的疾病,祖国传统中医学无颈椎病之病名,但根据其临床表现,当属痹症范畴,体虚之人感受风、寒、湿之邪,致使血脉凝涩不行或痰饮流注经络而成痹症。近年来,颈椎病已成为一种常见病,而且是一种顽疾。目前西医尚无有效药物和方法治疗,非甾体抗炎药、免疫调节药,只能起到临时缓解症状的作用,且毒副作用大,治疗成本高,停药后疼痛易复发,治愈率低。
发明内容
本发明目的在于提供一种补益肝肾、除湿涤痰、温经散寒、清热祛湿、活血通络、活血化瘀、行气通络,使寒邪得以温散,痰湿得以清化,气血运行通畅,调节全身气血运行,达到通经活络的目的,且无痛苦,无毒副作用,治疗成本低,治愈率高,而治疗颈椎病的中成药。
本发明的解决方案是基于祖国医学对颈椎病发病机理的认识及治疗原则,参考现代药理学研究,选用活血通络、祛风除湿类中草药,佐以清热、化痰类优质中草药,经采用配制、熬制、微粉加工等现代加工技术加工后,灌制成胶囊而成中成药,使血液流变得以改善,肢体血流量得以增加,改善肢体微循环,可明显改善颈部僵硬、麻木、疼痛等症状,用以治疗颈椎病,以达到治愈颈椎病的作用。本发明治疗颈椎病的中成药由纯中药配制而成,所以对人体无任何毒副作用。
本发明采取的技术方案是:
本发明治疗颈椎病的中成药配方及重量配比如下:桂枝10-20份、夏天无10-20份、当归20-40份、川芎10-15份、红花10-18份、刘寄奴20-30份、姜黄10-20份、路路通30-50份、羌活10-18份、白芷10-15份、威灵仙30-50份、桑枝20-40份、天南星10-20份、白芥子10-15份、葛根20-40份、双花20-40份、黄芩10-15份、天蔴10-15份、黄芪40-80份、狗脊10-15份、续断10-15份。
将上述各药按重量比例,经采用配制、熬制、微粉加工等现代加工技术加工后,灌制成胶囊服用。应用本发明中成药治疗颈椎病,疗效显著,清除症状迅速,服用方便,无毒副作用,治疗成本低。经临床试验,有效率96.8%,治愈率75.8%。
本发明中成药中,活血化瘀类药物为当归、川芎、姜黄、红花、桂枝、夏天无、刘寄奴、路路通;祛风通络类药物为羌活、白芷、威灵仙、桑枝、天蔴、狗脊;燥湿化痰类药物为天南星、白芥子、黄芩、续断;补气类药物为黄芪;清热解毒类药物为双花;解表类药物为葛根。
根据传统中医理论和现代医学研究证明。本发明中成药中,各种成份药物的性味归经及有效药物如下:
当归:性味,甘、辛、温,归心肝脾经,补血活血,含有挥发油、生物碱,有降低纤维蛋白原水平的作用。(①《中药学》308页,成都中医学院主编,1978年出版)
夏天无:性味,辛、苦、温。归肝经,活血、止疼、含延胡已素等。(同上①282页)
桂枝:性味,辛、甘、温,归心、肺、膀胱经,发汗解表,温经通阳,含挥发油、粘液汁及树汁等(同上①38页)
川芎:性味,辛、温,归肝、胆、心包经,行气活血,祛风止疼,含生物碱、挥发油,能直接扩张周围血管。(同上①见247页)
红花:性味,辛、温,归心肝经,活血通络,祛瘀止疼,含红花甙、红花黄色素,有抗血凝作用。(同上见254页)
刘寄奴:性味,辛、温,归肝、脾经,破血行瘀(②见新国医讲义教材53页)
姜黄:性味,辛、苦、温,归经脾经,破血行气,通经止疼,含挥发油,油中成份为姜黄酮,姜烯、淀粉等。(见①《中药学》成都中医学院主编257页)
路路通:性味,辛、苦、平,归肝、胃、膀胱经,祛风湿,通经络,含挥发油、桂皮醇、左旋龙脑等。(同上①221页)
羌活:性味,辛、苦、温,归膀胱、肾经,散寒解表,祛风湿,止疼,含挥发油、有机酸、生物碱等。(同上①见41页)
白芷:性味,辛、温,归肺、胃经,祛风解表,消肿止疼,含白芷素、挥发油等。(同上①42页)
威灵仙:性味,辛、温,归十二经,祛风除湿,通络止疼《本草正义》谓以走窜消克为能事,积湿停痰,血凝气滞,风寒湿之气,留凝隧络,关节不利诸病。含白头翁素,糖类皂甙等。(同上①211页)
桑枝:性味,苦、平,归肝经,祛风通络,《本草纲目》谓利关节,除风湿寒痹诸症,含桑素,葡萄糖等。(同上①218页)
天南星:性味,苦、辛、温,有毒,归肺、肝、脾经,燥湿化痰,祛风止痉,含安息香酸、淀粉等。(同上①104页)
白芥子:性味,辛、温,归肺经,温肺祛痰,利气散结,含芥子酶、芥子酸、脂肪油、蛋白质,《本草纲目》谓利气豁痰,除寒温中,散结止疼。(同上①106页)
狗脊:性味,苦、甘、温,归肝肾经,祛风湿,补肝肾,强腰膝,健骨,治周痹,含鞣质淀粉(同上①226页)
葛根;性味,甘、辛、凉,发表解肌,升阳透疹,有改善脑循环及外周循环的作用,含黄酮素类、淀粉等。(同上①50页)
双花:性味,甘、寒,归肺、胃、大肠经,清热解毒,含有还己六醇等,具有广谱抗菌作用。(同上①73页)
黄芪:性味,甘、微温,归脾、肺经,补气升阳,托毒生肌,含有糖类、胆碱等,有抗血栓形成,改善皮肤血液循环的作用。(同上①288页)
黄芩:性味,苦、寒,归肺、胆、胃、肝、大肠经,清热燥湿,泻火解毒,含黄芩素、黄芩疳等。(同上①61页)
续断:性味,苦、温,归肝、肾经,补肝肾,强筋骨,通血脉,有接骨疗伤的作用,含续断纤维、挥发油等。(同上①226页)
本发明中成药,以活血化瘀,除湿涤痰,温经散寒,清热祛湿,活血通络,清热解毒为出发点。配方中,活血化瘀药:当归,补血活血,有推陈致新之功;川芎,辛温香窜,走而不守,为活血行气之良药;姜黄,活血通络,行气止疼,祛风除痹,对上肢疼痛尤为专长;红花,通络活血,祛痰止疼;刘寄奴为破血行瘀之要药;路路通,行气通络,与刘寄奴相伍,有通行十二经,驱除经络瘀滞止疼之效;桂枝,有温经络,对风寒湿邪侵入经络所致的关节疼痛有较好效果;夏天无,止疼和通络作用比较明显,对风湿痹疼、麻木及跌打损伤,奏效甚快,且持续时间长。祛风通络药:狗脊,祛风湿,补肝肾,主腰背颈强;羌活,祛风之功胜于防风,长于祛风祛湿,又可通行关节而止疼;白芷,芳香,止疼开窍;威灵仙,善走能通十二经,为痹症之要药,对筋骨疼痛,肌肉麻痹,皆有一定作用;桑枝,祛湿通经络,达四肢,利关节,对风湿痹疼,四肢麻木,拘挛,皆有良好效果;续断,通利血脉,补肝肾,对风湿肢体疼痛,尤为专长;黄苓,有良好的清热燥湿解毒之功效;葛根,主诸痹,对改善头疼、头晕项强肢体麻木等症状有显著效果。燥湿化痰药物:天南星,化痰燥湿;白芥子,善能搜剔胸隔经络之痰,风痰阻滞气机或痰留经络肢体之症,皆能取效。补气类药物:黄芪为重要的补气药,善于升举阳气,使气旺以促血行,祛淤而不伤正;天蔴,主诸风湿痹,四肢构挛,利腰膝,强筋力及镇疼作用。
诸药合成,活血化瘀,行气通络,祛湿涤痰,起到温散寒邪,改善患者血液循环的作用,从而达到治愈颈椎病的目的。
为表明本发明中成药的疗效,对本发明中成药进行了临床治疗对比试验,根据统计试验组共248例,其中男104例,女136例,年龄在19岁-61岁之间,平均年龄41.6岁,病史1年-12年,平均6.2年,治疗方法为服用本发明中成药,每天3次,每次4粒,15天为一疗程,平均治疗时间为1-3个疗程。对照组共254例,其中男108例,女146例,年龄在19-61岁之间,平均年龄37.8岁,病史7-8年,平均4.5年,治疗方法为服用西药,如布洛芬、氯唑沙宗、萘普生等,每天3次,平均治疗时间1-4个疗程。并制定疗效标准如下:
痊愈:颈僵臂疼、手指发麻、背部沉重等诸症消失,不妨碍正常活动,随访1-3年,无复发。
显效:临床症状显著减轻。
好转:临床症状减轻,手指稍麻。
无效:临床症状症状及体征无改善者。
经立档留查和追踪调查,并进行统计分析对比,试验结果如下:
表1:试验组疗效情况
| 总人数 | 疗效情况 | |||||||
| 无效 | 好转 | 显效 | 痊愈 | |||||
| 人数 | % | 人数 | % | 人数 | % | 人数 | % | |
| 248 | 8 | 3.2 | 17 | 6.9 | 35 | 14.1 | 188 | 75.8 |
表2:对照组疗效情况
| 总人数 | 疗效情况 | |||||||
| 无效 | 好转 | 显效 | 痊愈 | |||||
| 人数 | % | 人数 | % | 人数 | % | 人数 | % | |
| 254 | 58 | 22.8 | 30 | 11.8 | 97 | 38.2 | 69 | 27.2 |
具体实施方式
下面结合实施例对本发明中成药做进一步的说明。
按下述重量配比选用优质中草药:桂枝12g、夏天无12g、当归24g、川芎12g、红花12g、刘寄奴24g、姜黄12g、路路通42g、羌活12g、白芷12g、威灵仙35g、桑枝34g、天南星15g、白芥子12g、葛根26g、双花26g、黄芩12g、天蔴102、黄芪60g、狗脊12g、续断12g。先将红花、姜黄、白芷、狗脊等四味药物采用微粉加工技术加工成细粉;其它药物煎熬3次(每次约2小时)收集煎液,浓缩成膏;然后把加工好的细粉加入浓缩膏中搅拌、调和,制成细小颗粒,灌装成胶囊,每粒胶囊重1.2g,每次4粒,每日3次,每15天为1疗程,服用该药1-5个疗程,可有效治疗腰椎间盘突出症。
从上述临床治疗对比试验中,随机选取2例,以进一步表明本发明中成药的治疗效果。
例1:邵玉景,女,39岁,阳谷县大布乡邵楼村人,2004年3月初诊,患者左臂疼,颈不能活动,手指(食、中指重)发麻一年有余。近月来诸症加重,疼痛不能卧,取半坐位,疼甚则满地行走,坐卧不宁,阴天夜间尤重,有时咳嗽,吐白粘痰。2003年2月,在本地医院拍片,颈椎增生,六、七椎间隙变窄,颈椎失去正常生理曲度,轻度变直,提示为颈椎病。口服本发明药物,每日3次,每次4粒,15天为1疗程,口服2个疗程后,疼痛减轻,能平卧睡眠,服4个疗程后,诸症消失。至今未见复发。
例2:李少敏,女,45岁,阳谷县张秋镇张庄村人。2004年初诊为颈椎病,一年有余,经多方治疗无效。于2005年3月来本发明人处求医,患者头疼,颈僵,头颈肩活动受限不适,耳鸣手麻,视物昏花,恶心呕吐,口服本发明药物,每日3次,每次4粒,15天为1疗程,口服3个疗程后,诸症减轻,按原方继服,5个疗程宣告痊愈。随访,至今未复发。
Claims (2)
1、一种治疗颈椎病的中成药,其特征在于它是由下述重量配比的各种成份的中药原料配制而成的中成药:桂枝10-20份、夏天无10-20份、当归20-40份、川芎10-15份、红花10-18份、刘寄奴20-30份、姜黄10-20份、路路通30-50份、羌活10-18份、白芷10-15份、威灵仙30-50份、桑枝20-40份、天南星10-20份、白芥子10-15份、葛根20-40份、双花20-40份、黄芩10-15份、天蔴10-15份、黄芪40-80份、狗脊10-15份、续断10-15份。
2、如权利要求1所述的治疗颈椎病的中成药,其特征在于各种成份的中药原料的最佳配比是:桂枝12g、夏天无12g、当归24g、川芎12g、红花12g、刘寄奴24g、姜黄12g、路路通42g、羌活12g、白芷12g、威灵仙35g、桑枝34g、天南星15g、白芥子12g、葛根26g、双花26g、黄芩12g、天蔴12g、黄芪60g、狗脊12g、续断12g。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510045395 CN1814245A (zh) | 2005-12-21 | 2005-12-21 | 一种治疗颈椎病的中成药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510045395 CN1814245A (zh) | 2005-12-21 | 2005-12-21 | 一种治疗颈椎病的中成药 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1814245A true CN1814245A (zh) | 2006-08-09 |
Family
ID=36906676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510045395 Pending CN1814245A (zh) | 2005-12-21 | 2005-12-21 | 一种治疗颈椎病的中成药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1814245A (zh) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101396541B (zh) * | 2008-10-09 | 2012-07-04 | 刘运波 | 一种治疗颈椎病的中药 |
| CN104587282A (zh) * | 2015-02-25 | 2015-05-06 | 胡运冲 | 一种治疗肝肾不足型项痹的中药组合物 |
| CN105105583A (zh) * | 2015-09-29 | 2015-12-02 | 谢芝见 | 一种颈椎保健枕配方 |
| CN105596570A (zh) * | 2015-12-26 | 2016-05-25 | 薛学明 | 一种治疗颈椎病的药物及其制备方法 |
| CN105816797A (zh) * | 2016-04-13 | 2016-08-03 | 河南省傅潭酒业有限公司 | 一种治疗颈椎病的中药酒及其制备方法 |
| CN106039045A (zh) * | 2016-06-23 | 2016-10-26 | 孙丰卿 | 一种用于治疗颈椎病的中药组合物及其制剂的制备方法 |
-
2005
- 2005-12-21 CN CN 200510045395 patent/CN1814245A/zh active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101396541B (zh) * | 2008-10-09 | 2012-07-04 | 刘运波 | 一种治疗颈椎病的中药 |
| CN104587282A (zh) * | 2015-02-25 | 2015-05-06 | 胡运冲 | 一种治疗肝肾不足型项痹的中药组合物 |
| CN105105583A (zh) * | 2015-09-29 | 2015-12-02 | 谢芝见 | 一种颈椎保健枕配方 |
| CN105596570A (zh) * | 2015-12-26 | 2016-05-25 | 薛学明 | 一种治疗颈椎病的药物及其制备方法 |
| CN105816797A (zh) * | 2016-04-13 | 2016-08-03 | 河南省傅潭酒业有限公司 | 一种治疗颈椎病的中药酒及其制备方法 |
| CN106039045A (zh) * | 2016-06-23 | 2016-10-26 | 孙丰卿 | 一种用于治疗颈椎病的中药组合物及其制剂的制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1390585A (zh) | 神阙排毒中药组合物及其制备方法 | |
| CN101396541B (zh) | 一种治疗颈椎病的中药 | |
| CN101062198A (zh) | 通痹汤 | |
| CN1814245A (zh) | 一种治疗颈椎病的中成药 | |
| CN104758743A (zh) | 一种治疗风湿病的中药泡脚粉及其制备和使用方法 | |
| CN1478525A (zh) | 跌打药酒 | |
| CN1478526A (zh) | 纯药酒 | |
| CN102188661A (zh) | 通痹中药及其制备方法 | |
| CN106309849A (zh) | 一种足浴用藏药组合物及其应用 | |
| CN101036706A (zh) | 活血化淤舒筋通络祛风湿酒 | |
| CN100998656A (zh) | 壮骨通络酒 | |
| CN103735647A (zh) | 一种治疗类风湿性关节炎的药酒 | |
| CN102406702B (zh) | 治疗鹤膝风的中药制剂 | |
| CN103599438B (zh) | 一种治疗骨病的中药酊及其制备方法 | |
| CN100346807C (zh) | 治疗骨关节疾病的熏洗用中药 | |
| CN105311210A (zh) | 治疗风湿骨病的药物组合物 | |
| CN1309406C (zh) | 一种治疗风湿类风湿疾病的药物制剂 | |
| CN103157072B (zh) | 一种用于治疗颈椎病的中药组合物 | |
| CN1843421A (zh) | 一种治疗风湿疾病的药物 | |
| CN1490018A (zh) | 一种治疗风湿病的药物 | |
| CN1380082A (zh) | 治疗妇科慢性炎症的中药 | |
| CN101954043A (zh) | 一种治疗骨质增生的药物及其制备方法 | |
| CN1422639A (zh) | 一种治疗风湿、类风湿性疾病的口服药物 | |
| CN100398143C (zh) | 一种治疗白癜风的药剂 | |
| CN101194997A (zh) | 一种治疗艾滋病的中药制剂及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |